Overview
Neuroinnovation group focused on patient-centered solutions.
Deals · 12mo
0
Links
Stage focus
Geographic focus
Sector focus
Investment portfolio
- Perceiv AI
Participated · Equity · Dec 2022
Perceiv AI develops Foresight, a proprietary AI/ML-driven prognostic platform that predicts disease progression to enable timely diagnosis of degenerative brain disorders and to optimize and de-risk clinical trials. The company says Foresight forecasts disease evolution to support physicians and trial design. Perceiv AI announced the closing of a $1.5 million investment from strategic and institutional investors from Canada and the U.S., including CABHI, Plug and Play Ventures, Boreal Ventures, IKJ Capital, Red Abbey Labs, Investissement Québec, and angel investors. The funds will be used to expand the Foresight platform and to add talent to advance commercial and scientific activities. Perceiv AI also plans to strengthen its regulatory effort. Investissement Québec participated as a representative of the government of Quebec.